Arcadia Biosciences’ Traits Increase Rice Yields By Double Digits
Published: May 08, 2018
Arcadia Biosciences (Nasdaq: RKDA) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. Arcadia’s GoodWheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. The company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. For more information visit www.arcadiabio.com.
About the International Center for Tropical Agriculture (CIAT)
The International Center for Tropical Agriculture (CIAT) – a CGIAR Research Center – develops technologies, innovative methods, and new knowledge that better enable farmers, especially smallholders, to make agriculture eco-efficient – that is, competitive and profitable as well as sustainable and resilient. Eco-efficient agriculture reduces hunger and poverty, improves human nutrition, and offers solutions to environmental degradation and climate change in the tropics. With headquarters near Cali, Colombia, CIAT conducts research for development in tropical regions of Africa, Asia, and Latin America. www.ciat.cgiar.org.
About The African Agricultural Technology Foundation (AATF)
The African Agricultural Technology Foundation (AATF) is a not-for-profit organization that facilitates and promotes public/private partnerships to access, develop, adapt and deliver appropriate agricultural technologies for sustainable use by smallholder farmers in Sub-Saharan Africa through innovative partnerships and effective stewardship along the entire value chain. It is headquartered in Nairobi, and its mandate covers sub-Saharan Africa. For more information, visit www.aatf-africa.org.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's expectations regarding its NUE, WUE and ST trait stacks and their impact on yields. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: the company’s and its partners’ and affiliates’ ability to identify and isolate desired traits; the company’s and its partners’ ability to develop commercial products incorporating its traits and complete the regulatory review process for such products; the company’s compliance with laws and regulations that impact the company’s business, and changes to such laws and regulations; the company’s future capital requirements and ability to satisfy its capital needs; and the other risks set forth in the company’s filings with the Securities and Exchange Commission from time to time, including the risks set forth in the company's Annual Report on Form 10-K for the year ended December 31, 2017. These forward-looking statements speak only as of the date hereof, and Arcadia Biosciences, Inc. disclaims any obligation to update these forward-looking statements.
Arcadia Biosciences, Inc.
Jeff Bergau, +1-312-217-0419
Source: Arcadia Biosciences, Inc.